USA DOMESTIC SHIPPING (WAREHOUSE 4)
cRowX Labs, Tirzerow (Tirzepatide) 5mg/vial.
Tirzepatide (Tirzerow cRowX Labs) 5mg in vial is an antidiabetic medication used for the treatment of type 2 diabetes and for weight loss. Tirzepatide is administered through subcutaneous injection (under the skin)
Tirzepatide was approved for medical use in the United States in May 2022, in the European Union in September 2022, in Canada in November 2022 and in Australia in December 2022.The US Food and Drug Administration (FDA) considers it to be a first-in-class medication. It was approved by the FDA for weight loss in November 2023!